Utilization Management: Types, Process, and What Employers Need to Know
Key Takeaways
- The evidence that utilization management saves money is strongest for targeted case management of high-cost members and weakest for high-volume prior authorization, where net savings remain disputed.
- Self-funded employers have more leverage than they use over utilization management design, including which services require prior authorization, which clinical criteria apply, and what reporting they receive.
- Utilization management decides whether care happens, but it has no mechanism to influence which provider delivers that care or how good the outcome is.
Utilization management has been standard in health plans for decades. Prior authorization, concurrent review, and case management have all been running as designed the whole time, but healthcare costs keep climbing anyway. Employers now face a projected 9% medical cost trend for 2026, the highest in more than a decade, and the tools built to control utilization have not solved the cost problem.
None of that means the tools are useless. It means their value depends on knowing what utilization management can actually control, and what it was never built to touch, starting with who delivers the care it approves.
What is utilization management?
Utilization management is a set of clinical review processes that health plans, insurers, third-party administrators (TPAs), and self-funded employers use to evaluate whether medical services are medically necessary, appropriate, and cost-effective. That evaluation can happen before care is delivered, while it is in progress, or after it is complete.
The term is often used interchangeably with utilization review (UR). Strictly speaking, utilization review refers to the retrospective evaluation of care that has already been delivered, which makes it a subset of utilization management. In practice, even plan documents rarely keep the two straight.
Who runs utilization management depends on how the plan is structured. Fully insured plans rely on the carrier's own UM team, while self-funded employers typically inherit whatever program their TPA administers, or they contract with an independent UM vendor. That structure matters, because self-funded employers have far more control over UM program design than is commonly understood.
Accreditation bodies such as URAC and NCQA set the standards these programs are measured against, covering reviewer qualifications, decision timeframes, the clinical criteria in use, and appeals handling.
Types of utilization management reviews
Every utilization management program is built from three review types, differentiated by when the review happens relative to care.
Prospective review and prior authorization
Prospective review requires approval before a service is delivered, and prior authorization (PA) is the form it most often takes. The provider submits clinical information to the health plan or UM vendor, the plan applies evidence-based medical necessity criteria, and the request is approved, modified, or denied before care proceeds. Some plan documents call this pre-certification, and the two terms are used interchangeably in most contexts.
Prior authorization applies to inpatient and outpatient services alike, and increasingly to specialty drugs and other high-cost interventions. The provider-side workload is substantial. In the American Medical Association's 2025 survey, physicians reported completing 40 prior authorizations per week on average, consuming 13 hours of physician and staff time.
Concurrent review
Concurrent review monitors care while it is in progress, most commonly during inpatient hospital stays. A utilization management nurse or clinical reviewer assesses whether continued inpatient care remains medically justified, using evidence-based length-of-stay benchmarks and level-of-care criteria.
Discharge planning starts here too. When a reviewer determines a patient no longer needs acute-level care, that decision often triggers or accelerates coordination of post-acute care.
Retrospective review
Retrospective review evaluates care after it has been delivered, deciding whether it was clinically appropriate and eligible for coverage. Its most common uses are claims auditing, coding accuracy checks, and identifying patterns of inappropriate utilization across a population.
Retrospective denials are the most frustrating kind for employees and providers, because the care has already happened and the denial carries all of the financial friction of prospective review with none of its preventive benefit.
How the utilization management process works
From the plan or employer perspective, the review process follows a consistent workflow:
- The provider submits a request with supporting clinical documentation
- The UM team applies clinical criteria to the request, with InterQual and MCG (formerly Milliman Care Guidelines) serving as the two dominant evidence-based frameworks
- A decision is issued to approve, modify, or deny the request
- If denied, the ordering physician can request a peer-to-peer review with a plan medical director
- If the denial stands, a formal appeals process follows, with timelines set by regulation and plan documents
Clinical criteria deserve a closer look, because they decide the outcome long before an appeal ever starts. They are the evidence-based decision rules that determine what counts as medically necessary, and how rigorous and current they are varies from one UM vendor or health plan to the next. When the criteria are out of date, the plan ends up denying care it should approve and approving care it shouldn't.
What utilization management can and can't control
Utilization management is designed to do three things:
- Evaluate whether specific services meet medical necessity criteria
- Reduce duplicative and low-evidence care
- Manage plan costs at the service-authorization level
However, once care is authorized, it cannot:
- Improve the quality of that care
- Influence which provider delivers it
- Prevent the downstream costs of a poor clinical outcome, including complications, readmissions, and the additional interventions that follow
Consider two employees who both clear prior authorization for the same elective procedure. The authorization process treats them identically. Their outcomes may be anything but, depending on who performs the procedure. An analysis of claims data covering 320 million patients found that top-performing physicians have 75% lower complication rates and 60% lower hospitalization rates than their peers. Utilization management has no way to close that gap, because it reviews the service, never the provider delivering it.
Utilization management and healthcare costs: what the evidence shows
The research on the cost impact of utilization management is more nuanced than most vendor marketing suggests.
The strongest evidence supports case management for high-complexity, high-cost members. A systematic review in the American Journal of Managed Care examined 29 studies and found case management frequently cost-effective or outright cost-saving, with returns as high as 12.2:1 for complex case management of adults with multiple comorbidities. The evidence for disease management programs for chronic conditions is positive on the whole but more mixed.
The evidence is weaker for high-volume prior authorization applied to routine services, where the administrative cost is real and well documented. The 2024 CAQH Index estimates that moving prior authorization to fully electronic standards would save the industry $515 million a year and save providers 14 minutes per authorization. Whether high-volume PA generates net savings after that overhead is disputed. The Business Group on Health has documented that many employers lack clear visibility into whether their PA programs are producing savings or simply adding process.
The useful question, then, is not whether utilization management exists in the plan. It is whether the program produces better patient outcomes and cost-effective care, or friction that outweighs the benefit.
Utilization management for self-funded employers
Most utilization management content treats the employer as a bystander. However, self-funded plans have far more room to shape UM program design than fully insured arrangements, where the carrier's program comes as-is.
A self-funded employer can influence which services require prior authorization, which clinical criteria standards its TPA applies, and whether to bring in an independent UM vendor. It can also decide what reporting it receives, including PA volume, denial rates, and appeal outcomes.
Utilization management trends shaping 2026
Four developments are reshaping how utilization management operates in 2026.
Federal prior authorization reform. CMS finalized rules requiring Medicare Advantage, Medicaid, CHIP, and exchange plans to decide expedited prior authorization requests within 72 hours and standard requests within seven calendar days, and to publicly report PA metrics. Similar pressure is building in commercial markets through state legislation and federal proposals extending electronic prior authorization to drugs.
AI in the utilization management review process. Health plans and UM vendors are deploying AI to accelerate medical necessity decisions and reduce administrative burden. Clinical and accreditation bodies are actively debating what standards should govern AI-assisted UM decisions.
Value-based care and embedded utilization management. As value-based arrangements mature, UM logic is increasingly written into provider contracts and accountable care arrangements. That shifts review responsibility upstream and reduces case-by-case authorization volume.
Member experience as a plan quality metric. PA delays and denials now show up directly in how employees rate their health benefits. Employers are beginning to treat UM friction as a benefits design variable rather than an administrative footnote.
Provider quality: the variable utilization management doesn't measure
Every review type, from prior authorization to retrospective audit, shares the same blind spot. Utilization management measures whether care should happen, not how good that care will be. If utilization management addresses how much care is used, what addresses how good that care is? That is the question it was never built to answer.
Garner works on that side of the problem, directing employees to the best-performing doctors already in their existing network, with no network changes required.
Utilization management tells you whether care is authorized, but Garner tells you whether that care is being delivered by the right provider. Book a demo to see how it works for employers like yours.
FAQs
What is the difference between utilization management and utilization review?
Utilization review is technically a subset of utilization management. It refers to the retrospective evaluation of care that has already been delivered, while utilization management covers the full set of review processes, including prior authorization and concurrent review. In everyday industry usage, the two terms are treated as interchangeable, even in plan documents.
Does utilization management actually reduce healthcare costs?
It depends on the program. Peer-reviewed evidence supports case management for high-complexity, high-cost members, which is frequently cost-effective or cost-saving. The evidence for high-volume prior authorization of routine services is weaker, since the administrative burden is substantial and net savings are disputed. Many employers also lack the reporting to judge whether their own program saves money.
Can employers change how utilization management works in their health plan?
Self-funded employers can. They can influence which services require prior authorization, which clinical criteria their TPA applies, whether to bring in an independent UM vendor, and what reporting they receive on denial rates and appeal outcomes. Fully insured employers have less leverage, since the carrier controls the program, though they can still request reporting and raise UM friction at renewal.
What happens when a prior authorization request is denied?
The ordering physician can usually request a peer-to-peer review, a conversation with a plan medical director to argue the clinical case. If the denial stands, the member or provider can file a formal appeal, with timelines set by regulation and plan documents. A meaningful share of denials are overturned on appeal, which is why overturn rates are worth tracking.